4.8 Article

Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy

Journal

ACS NANO
Volume 12, Issue 12, Pages 11740-11755

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.8b05893

Keywords

nanoparticles; cancer; immunotherapy; tumor microenvironment; nanovaccine; cytokines; checkpoint inhibitors; immunogenic cell death; cytotoxic T cells

Funding

  1. Carolina Center for Cancer Nanotechnology Excellence (NIH) [CA198999]

Ask authors/readers for more resources

Nanoscience has long been lauded as a method through which tumor-associated barriers could be overcome. As successful as cancer immunotherapy has been, limitations associated with the tumor microenvironment or side effects of systemic treatment have become more apparent. In this Review, we seek to lay out the therapeutic challenges associated with the tumor microenvironment and the ways in which nanoscience is being applied to remodel the tumor microenvironment and increase the susceptibility of many cancer types to immunotherapy. We detail the nanomedicines on the cutting edge of cancer immunotherapy and how their interactions with the tumor microenvironment make them more effective than systemically administered immunotherapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available